Strategist's Digest
This month
AI foresight, pharma's next era, and what's new on the platform
In this issue: Two-thirds of foresight practitioners now use AI, but most are getting generic outputs that miss the strategic point. This month's lead piece breaks down exactly where AI adds real value, and where human judgment can't be replaced.
Plus: 9 megashifts reshaping pharma that belong on every strategist's radar right now.
What's new on the Trendtracker platform →

